Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1425 - 1432 of 11617 results
MintzTech Connect: All Things Technology — February 2023
February 21, 2023| Article| Viewpoint
Federal Judge Allows Antitrust Claims to Proceed Against Hospital System and Vertically-Integrated Physician Group
February 21, 2023| Blog| Viewpoint
CMS Proposes New Disclosure of Ownership Regulations for Nursing Facilities - Top Five Takeaways for Private Equity Firms and REITs
February 21, 2023| Blog| Viewpoint
Federal Court Kicks California Arbitration Ban to the Curb
February 21, 2023| Blog| Viewpoint
The Rise of Whistleblower Tips (and Rewards) for Crypto Sleuths
February 17, 2023| Blog| Viewpoint
Fifth Circuit Provides New Guidance on Evaluating Confidential Witnesses
February 16, 2023| Blog| Viewpoint
IRA Update: IRS Releases Limited Guidance on Low-Income Community Adder and Establishes Allocation Program Needed to Make the Adder Available
February 16, 2023| Alert| Viewpoint
Ruling Casts Shadow On Cannabis Employees' Ch. 13 Relief
February 16, 2023| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.
Events
Podcasts
The ‘Third Inning’ of the Energy Transition
December 6, 2024| Podcast|
Mintz on Air - Predictions and Practical Policies
November 25, 2024| Podcast|